Free Trial

Ampio Pharmaceuticals (AMPE) SEC Filings & 10K Form

$0.25
+0.02 (+8.70%)
(As of 05/24/2024 ET)

Recent Ampio Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/04/2024
12:32 PM
Ampio Pharmaceuticals (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
03/27/2024
3:29 PM
Ampio Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
4:25 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
11:15 PM
Ampio Pharmaceuticals (Filer)
Form EFFECT
02/28/2024
2:45 PM
Ampio Pharmaceuticals (Filer)
Form RW
02/28/2024
2:46 PM
Ampio Pharmaceuticals (Filer)
Form POS AM
02/28/2024
2:47 PM
Ampio Pharmaceuticals (Filer)
Form S-8 POS
02/28/2024
2:48 PM
Ampio Pharmaceuticals (Filer)
Form S-8 POS
02/28/2024
2:49 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
8:31 AM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:20 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
3:25 PM
Ampio Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/07/2023
9:20 AM
Ampio Pharmaceuticals (Subject)
Terker Bruce E (Filed by)
Form SC 13G/A
11/14/2023
3:10 PM
Ampio Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
8:30 AM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
1:10 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
1:56 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
3:15 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2023
11:15 PM
Ampio Pharmaceuticals (Filer)
Form EFFECT
09/22/2023
3:30 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:30 PM
Ampio Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/15/2023
3:56 PM
Ampio Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/13/2023
10:33 AM
Ampio Pharmaceuticals (Filer)
Form DEFA14A
07/05/2023
3:37 PM
Ampio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
4:14 PM
Ampio Pharmaceuticals (Filer)
Form DEF 14A
06/13/2023
11:07 AM
Ampio Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
1:26 PM
Ampio Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
4:19 PM
Ampio Pharmaceuticals (Filer)
Form PRE 14A
05/26/2023
12:30 PM
Ampio Pharmaceuticals (Issuer)
MARTINO MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:AMPE) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners